Monoclonal Immunoglobulin Deposition Disease

Monoclonal Immunoglobulin Deposition Disease — Trials · CancerIndex

Clinical trials

Registered studies

148 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01169337	Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma	active not recruiting	Phase 3	226	National Cancer Institute (NCI)NIH	3	Aug 4, 2026	clinicaltrials
NCT04504825	A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)	active not recruiting	Phase 3	125	Alexion Pharmaceuticals, Inc.INDUSTRY	19	Jul 2, 2026	clinicaltrials